💊 Formoterol and budesonide (Budesonide And Formoterol Fumarate Dihydrate)
Budesonide and formoterol is a prescription inhaler combining a corticosteroid with a long-acting beta2-agonist. It is used to treat asthma in patients 6 years and older and for maintenance treatment of airflow obstruction and to reduce exacerbations in COPD. It is not for relief of acute bronchospasm.
In Arabic: بوديزونيد وفورموتيرول✅ What it is used for
- Treatment of asthma in patients 6 years of age and older, particularly those not adequately controlled on a long-term control medication such as an inhaled corticosteroid, or whose disease warrants starting both an inhaled corticosteroid and a LABA
- Maintenance treatment of airflow obstruction in COPD, including chronic bronchitis and/or emphysema (160/4.5 strength only)
- Reducing exacerbations of COPD
- Not indicated for relief of acute bronchospasm
🧪 Active ingredient
Budesonide is an anti-inflammatory corticosteroid that reduces airway inflammation; formoterol is a selective long-acting beta2-agonist that relaxes and opens the airways.
🌿 Benefits
- Helps control asthma symptoms; improvement can occur within 15 minutes, with maximum benefit possibly taking 2 weeks or longer
- Improves airflow obstruction in COPD
- Reduces COPD exacerbations
📝 How to use
- For oral inhalation only; your doctor or pharmacist determines your dose
- Usually 2 inhalations twice daily (morning and evening, about 12 hours apart), every day
- Rinse your mouth with water after inhaling and do not swallow the water
- Before first use: shake well for 5 seconds and release two test sprays into the air away from the face, shaking before each spray
- If not used for more than 7 days or if dropped, prime again in the same way
- Do not use more inhalations or more frequent doses than prescribed, and do not use another LABA with it
- If asthma symptoms occur between doses, use an inhaled short-acting beta2-agonist for immediate relief
💊 Dosage forms
- Inhalation aerosol (metered-dose inhaler) in two strengths: budesonide/formoterol 80/4.5 and 160/4.5 mcg per actuation
- Each canister contains 120 actuations
⚠️ Common side effects
- Nasopharyngitis
- Headache
- Upper respiratory tract infection
- Pharyngolaryngeal pain
- Sinusitis
- Influenza
- Back pain
- Nasal congestion
- Stomach discomfort
- Vomiting
- Oral candidiasis (thrush)
- Bronchitis (in COPD)
🚨 Serious — seek medical help
- Serious asthma-related events (hospitalization, intubation, death)
- Pneumonia or lower respiratory tract infections in COPD patients
- Paradoxical bronchospasm (worsened wheezing right after inhalation), requiring discontinuation
- Cardiovascular and central nervous system effects
- Hypercorticism and adrenal suppression
- Growth effects in children
- Glaucoma and cataracts
- Immunosuppression and worsening of infections
⛔ Do not use if
- Primary treatment of status asthmaticus or other acute episodes of asthma or COPD requiring intensive measures
- Hypersensitivity to any ingredient of the product
❗ Warnings & precautions
- Not for relief of acute symptoms and should not be started during acutely deteriorating asthma or COPD
- LABA monotherapy increases the risk of serious asthma-related events
- Do not use with another long-acting beta2-agonist because of overdose risk
- Risk of Candida infection of the mouth and throat; rinse the mouth after each use
- Monitor COPD patients for signs of pneumonia
- Use with caution in patients with infections (tuberculosis, fungal, bacterial, viral, parasitic, ocular herpes simplex); chickenpox or measles can be more serious in susceptible patients
- When transferring from oral corticosteroids, taper them slowly
- Very high doses, or regular doses in susceptible individuals, may cause hypercorticism and adrenal suppression
- Use with caution in cardiovascular or CNS disorders
- Assess bone mineral density initially and periodically
- May reduce growth velocity in children
🔄 Drug interactions
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin): may increase systemic corticosteroid effects; use with caution
- MAO inhibitors and tricyclic antidepressants (or within 2 weeks of stopping them): may potentiate formoterol's vascular effects; use with extreme caution
- Beta-blockers: may block bronchodilation and cause severe bronchospasm
- Non-potassium-sparing diuretics: ECG changes and/or hypokalemia may worsen with beta-agonists
- No formal interaction studies were performed; short-acting beta2-agonists, intranasal corticosteroids and antihistamines/decongestants did not increase adverse reactions in clinical studies
🤰 Pregnancy
There are no adequate and well-controlled studies of this combination in pregnant women. In animal studies the combination and its components showed adverse effects on the fetus (malformations, reduced fetal weight). Studies in pregnant women have not shown that inhaled budesonide alone increases the risk of abnormalities. Poorly controlled asthma itself increases pregnancy risks. Consult your doctor before use during pregnancy.
🍼 Breastfeeding
The label text provided does not give sufficient information on breastfeeding; consult your doctor before use while breastfeeding.
🧒 Children
Safe and effective for asthma in patients 6 years and older (80/4.5 strength for ages 6 to less than 12 years). Safety and effectiveness under 6 years have not been established. Inhaled corticosteroids may reduce growth velocity in children, and the long-term effect on final height is unknown. Only the 160/4.5 strength is indicated for COPD.
👴 Older adults
No overall differences in safety or effectiveness were seen between older and younger patients, and no dose adjustment is warranted. Special caution is advised in older patients with concomitant cardiovascular disease that could be adversely affected by beta2-agonists.
🌡️ Storage
Detailed storage conditions are not given in the label text provided; follow the packaging instructions and your pharmacist's advice.
⏰ Missed dose
The label text provided does not address missed doses; do not double up and ask your doctor or pharmacist. Do not exceed 2 inhalations twice daily.
🆘 Overdose
Formoterol overdose may exaggerate beta2-agonist effects: seizures, angina, hypertension or hypotension, tachycardia, arrhythmias, nervousness, headache, tremor, palpitations, muscle cramps, nausea, dizziness, sleep disturbances, metabolic acidosis, hyperglycemia, hypokalemia; cardiac arrest may occur. Prolonged excessive budesonide may cause hypercorticism. Seek medical help immediately.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Budesonide: corticosteroid with potent glucocorticoid and weak mineralocorticoid activity, inhibiting multiple inflammatory cell types and mediators. Formoterol: selective long-acting beta2-adrenoceptor agonist. The two components have different effects on clinical, physiological and inflammatory indices in asthma and COPD.
Labeled dosing
Oral inhalation only. Asthma ≥12 years: 2 inhalations of 80/4.5 or 160/4.5 twice daily, starting dose based on asthma severity; maximum 160/4.5, 2 inhalations twice daily. Asthma 6 to <12 years: 2 inhalations of 80/4.5 twice daily. COPD: 2 inhalations of 160/4.5 twice daily. The dose is individualized by the prescriber.
- Not for acute bronchospasm
- Prime before first use and after >7 days of non-use or dropping
- Mouth rinse after inhalation
- Do not add another LABA
- Monitor for oral candidiasis, pneumonia (COPD), adrenal effects, growth, eye effects and bone mineral density
- Hepatic impairment: monitor for signs of increased drug exposure
🎓 Key points for students
- Inhaled corticosteroid + LABA combination in a metered-dose inhaler
- LABA monotherapy increases risk of serious asthma-related events
- Not a rescue medication for acute bronchospasm
- Budesonide is metabolized by CYP3A4; strong inhibitors raise systemic exposure
- Beta-blockers may antagonize bronchodilation and cause severe bronchospasm
- Characteristic local adverse effect is oral candidiasis, reduced by rinsing the mouth
- Only the 160/4.5 strength is approved for COPD
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
Can I use it during a sudden asthma attack?
No. It is not indicated for relief of acute bronchospasm. An inhaled short-acting beta2-agonist is used for symptoms between doses; talk to your doctor.
Why must I rinse my mouth after inhaling?
To reduce the risk of Candida (thrush) infection of the mouth and throat. Rinse with water and do not swallow it.
How often is it used?
Usually 2 inhalations twice daily about 12 hours apart, but your doctor or pharmacist sets your dose; do not exceed what is prescribed.
How soon does it work?
Asthma control may improve within 15 minutes, though maximum benefit may take 2 weeks or longer, and this varies between people.
Is it suitable for children?
Yes for asthma in children 6 years and older, using the 80/4.5 strength for ages 6 to less than 12. Safety under 6 years has not been established, and inhaled corticosteroids may slow growth, so doctors monitor this.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2024-10), simplified. Updated: 2026-11-16.